Finance

Lists
VNDA:NASDAQ
Vanda Pharmaceuticals Inc.
$4.09
+1.49%
(+0.060) 1D
$4.14
+1.22% (+0.050)
After hours
Closed: Oct 19, 4:00:00ā€ÆPM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VNDA...
Open
$4.06
High
$4.12
Low
$4.04
Mkt. cap
247.29M
Avg. vol.
1.02M
Volume
671.32K
52-wk high
$9.94
52-wk low
$4.00
EPS
-$4.63
Beta
0.69
Shares outstanding
60.46M
No. of employees
533
Open
$4.06
High
$4.12
Low
$4.04
Mkt. cap
247.29M
Avg. vol.
1.02M
Volume
671.32K
52-wk high
$9.94
52-wk low
$4.00
EPS
-$4.63
Beta
0.69
Shares outstanding
60.46M
No. of employees
533
News stories
From web sources and news partners
About Vanda Pharmaceuticals Inc.
CEO-
Employees533
Founded2002
HeadquartersWashington, Washington, United States
SectorBiotechnology
Websitevandapharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to VNDA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VNDA in the last 3 months.
Highest
Current $4.09
$20.00 (+389.00%)
Average
$13.25 (+223.96%)
Lowest
$10.00 (+144.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+389%
10/05/2026
Les Sulewski
Oppenheimer
Buy
Initiated
$10.00
+144.5%
09/23/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
$10.00
+144.5%
09/23/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
$12.00
+193.4%
08/10/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Reiterated
$11.00
+168.9%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
56.26M
57.22M
51.72M
50.53M
Cost of goods sold
2.95M
3.83M
3.16M
3.56M
Cost of revenue
2.95M
3.83M
3.16M
3.56M
Research and development expenses
22.56M
29.01M
28.44M
36.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.27M
62.98M
68.36M
71.84M
Operating expense
84.59M
93.74M
98.78M
110.78M
Total operating expenses
87.54M
97.57M
101.94M
114.34M
Operating income
-31.28M
-40.35M
-50.22M
-63.81M
Other non operating income
-
-
1.80M
-
EBT including unusual items
-28.39M
-38.00M
-48.42M
-62.38M
EBT excluding unusual items
-28.39M
-40.06M
-48.42M
-62.38M
Income tax expense
-5.80M
103.18M
143.00K
129.00K
Effective tax rate
20.44%
-271.53%
-0.30%
-0.21%
Other operating expenses
-
-
-
-
Net income
-22.59M
-141.19M
-48.57M
-62.51M
Net profit margin
-40.15%
-246.76%
-93.91%
-123.72%
Earnings per share
-
-
-
-
Interest and investment income
2.89M
298.00K
-
1.42M
Interest expense
-
-
-
-
Net interest expenses
2.89M
298.00K
-
1.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.23M
-38.30M
-47.96M
-61.56M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps